Core Viewpoint - Changfeng Pharmaceutical (02652.HK) made its debut on the Hong Kong Stock Exchange on October 8, 2023, with a significant opening increase of 218.64% [1] Group 1: Stock Performance - The opening price was set at HKD 47 per share, with the stock price peaking at over 220% during trading [1] - As of the latest update, the stock has slightly retraced to HKD 41.6 per share, reflecting a still substantial increase of 182% [1] Group 2: Company Focus - Changfeng Pharmaceutical specializes in the research, development, production, and commercialization of inhalation technology and inhalation drugs [1] - The company targets the treatment of respiratory diseases and has developed a diverse product portfolio that addresses a wide range of patients, medical specialties, and treatment areas [1]
长风药业上市首日大涨逾220%